284 related articles for article (PubMed ID: 18359354)
21. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
White WM; Pickens RB; Doggweiler R; Klein FA
J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Frey's syndrome with botulinum toxin.
Pomprasit M; Chintrakarn C
J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
de Ru JA; Buwalda J
J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
[TBL] [Abstract][Full Text] [Related]
24. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
Singer C; Papapetropoulos S
Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
[TBL] [Abstract][Full Text] [Related]
25. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
[TBL] [Abstract][Full Text] [Related]
26. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
[TBL] [Abstract][Full Text] [Related]
27. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland.
Montoya FJ; Riddell CE; Caesar R; Hague S
Eye (Lond); 2002 Nov; 16(6):705-9. PubMed ID: 12439663
[TBL] [Abstract][Full Text] [Related]
28. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
von Lindern JJ
Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
30. Botox in the dental office--is it worth the risk?
Thomason R
Pa Dent J (Harrisb); 2007; 74(4):54-5. PubMed ID: 17874579
[No Abstract] [Full Text] [Related]
31. Treatment of aberrant facial nerve regeneration with botulinum toxin A.
Chua CN; Quhill F; Jones E; Voon LW; Ahad M; Rowson N
Orbit; 2004 Dec; 23(4):213-8. PubMed ID: 15590522
[TBL] [Abstract][Full Text] [Related]
32. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
Mazo EB; Krivoborodov GG; Efremov NS
Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
[TBL] [Abstract][Full Text] [Related]
33. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
Song PC; Schwartz J; Blitzer A
Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin in the treatment of refractory vaginismus.
Ghazizadeh S; Nikzad M
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):922-5. PubMed ID: 15516379
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study.
Wittekindt C; Liu WC; Preuss SF; Guntinas-Lichius O
Laryngoscope; 2006 Jul; 116(7):1168-71. PubMed ID: 16826054
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type A for the treatment of nummular headache: four case studies.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Mar; 48(3):442-7. PubMed ID: 18028377
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin reduces anal spasm but has no effect on pain after haemorrhoidectomy.
Singh B; Box B; Lindsey I; George B; Mortensen N; Cunningham C
Colorectal Dis; 2009 Feb; 11(2):203-7. PubMed ID: 18462246
[TBL] [Abstract][Full Text] [Related]
38. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
Krohel GB; Cipollo CL; Gaddipati K
Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
[TBL] [Abstract][Full Text] [Related]
39. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic properties of different formulations of botulinum neurotoxin type A.
Wohlfarth K; Kampe K; Bigalke H
Mov Disord; 2004 Mar; 19 Suppl 8():S65-7. PubMed ID: 15027057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]